BCC4
MCID: BSL027
MIFTS: 17

Basal Cell Carcinoma 4 (BCC4)

Categories: Cancer diseases, Genetic diseases, Rare diseases, Respiratory diseases, Skin diseases

Aliases & Classifications for Basal Cell Carcinoma 4

MalaCards integrated aliases for Basal Cell Carcinoma 4:

Name: Basal Cell Carcinoma 4 57
Basal Cell Carcinoma, Susceptibility to, 4 57 13 72
Bcc4 57

Classifications:



External Ids:

OMIM 57 613061
UMLS 72 C2751602

Summaries for Basal Cell Carcinoma 4

MalaCards based summary : Basal Cell Carcinoma 4, also known as basal cell carcinoma, susceptibility to, 4, is related to basal cell carcinoma. An important gene associated with Basal Cell Carcinoma 4 is BCC4 (Basal Cell Carcinoma, Susceptibility To, 4). The drugs Fludarabine and rituximab have been mentioned in the context of this disorder. Affiliated tissues include skin.

More information from OMIM: 613061

Related Diseases for Basal Cell Carcinoma 4

Diseases in the Small Cell Carcinoma family:

Basal Cell Carcinoma 1 Basal Cell Carcinoma 2
Basal Cell Carcinoma 3 Basal Cell Carcinoma 4
Basal Cell Carcinoma 5 Basal Cell Carcinoma 6
Basal Cell Carcinoma 7 Cell Type Cancer
Basal Cell Carcinoma Large Cell Carcinoma
Basal Cell Carcinoma, Multiple

Diseases related to Basal Cell Carcinoma 4 via text searches within MalaCards or GeneCards Suite gene sharing:

# Related Disease Score Top Affiliating Genes
1 basal cell carcinoma 11.4

Symptoms & Phenotypes for Basal Cell Carcinoma 4

Clinical features from OMIM:

613061

Drugs & Therapeutics for Basal Cell Carcinoma 4

Drugs for Basal Cell Carcinoma 4 (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 17)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Fludarabine Approved Phase 2 21679-14-1, 75607-67-9 30751
2
rituximab Approved Phase 2 174722-31-7 10201696
3
Vidarabine Approved, Investigational Phase 2 24356-66-9 21704 32326
4 Hemagglutinins Phase 2
5 Agglutinins Phase 2
6 Immunosuppressive Agents Phase 2
7 Cold agglutinins Phase 2
8 Antibodies Phase 2
9 Anti-Infective Agents Phase 2
10 Antineoplastic Agents, Immunological Phase 2
11 Immunoglobulins Phase 2
12 Immunologic Factors Phase 2
13 Antibodies, Monoclonal Phase 2
14 Antiviral Agents Phase 2
15 Antimetabolites Phase 2
16 Antirheumatic Agents Phase 2
17 Antimetabolites, Antineoplastic Phase 2

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 Therapy for Chronic Cold Agglutinin Disease: A Prospective, Non-randomized International Multicentre Study on the Safety and Efficacy of Rituximab in Combination With Fludarabine. Completed NCT00373594 Phase 2 Rituximab;Fludarabine

Search NIH Clinical Center for Basal Cell Carcinoma 4

Genetic Tests for Basal Cell Carcinoma 4

Anatomical Context for Basal Cell Carcinoma 4

MalaCards organs/tissues related to Basal Cell Carcinoma 4:

41
Skin

Publications for Basal Cell Carcinoma 4

Articles related to Basal Cell Carcinoma 4:

# Title Authors PMID Year
1
New common variants affecting susceptibility to basal cell carcinoma. 8
19578363 2009
2
Value of p63 and podoplanin (D2-40) immunoreactivity in the distinction between primary cutaneous tumors and adenocarcinomas metastatic to the skin: a clinicopathologic and immunohistochemical study of 79 cases. 38
20377670 2010
3
Survival and function in patients with tumours of the head and neck operated on and reconstructed with free flaps. 38
18335351 2008
4
Experience with eyelid-sparing orbital exenteration: the 2000 Tullos O. Coston Lecture. 38
11642492 2001
5
Cutaneous melanoma of the eyelid. Clinicopathologic features. 38
1775323 1991
6
Squamous cell carcinoma of the eyelids. 38
3601369 1987
7
Distribution of keratin proteins in neoplastic and tumorlike lesions of squamous epithelium. An immunohistochemical study. 38
2579363 1985

Variations for Basal Cell Carcinoma 4

Expression for Basal Cell Carcinoma 4

Search GEO for disease gene expression data for Basal Cell Carcinoma 4.

Pathways for Basal Cell Carcinoma 4

GO Terms for Basal Cell Carcinoma 4

Sources for Basal Cell Carcinoma 4

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 TGDB
71 Tocris
72 UMLS
73 UMLS via Orphanet
Content
Loading form....